Epiphron Capital

Epiphron Capital is a dedicated investment firm specializing in healthcare funds. The firm typically invests in Series B rounds, focusing on companies within the healthcare sector. Their investment strategy centers on identifying and supporting innovative healthcare solutions that have the potential to make significant impacts in the industry.

Notable portfolio companies include Clarapath, which has raised $16 million with Epiphron's support. The firm's key partners and decision-makers bring extensive experience from leading healthcare and investment institutions, providing strategic guidance and industry insights. Epiphron Capital offers unique value-add services such as operational support, strategic partnerships, and access to a broad network of industry experts to help portfolio companies scale effectively.